Phthalazine PDE4 inhibitors. Part 2: The synthesis and biological evaluation of 6-methoxy-1,4-disubstituted derivatives

Bioorganic & Medicinal Chemistry Letters
2001.0

Abstract

This communication describes the synthesis and in vitro evaluation of a novel and potent series of phosphodiesterase type IV (PDE4) inhibitors. The compounds described present substituents in position 4 of the phthalazine ring to replace the commonly observed cyclopentyloxy moiety of rolipram analogues. Preliminary evidences of reduced side effects compared to standards and improved pharmacokinetic properties for selected derivatives are also reported.

Knowledge Graph

Similar Paper

Phthalazine PDE4 inhibitors. Part 2: The synthesis and biological evaluation of 6-methoxy-1,4-disubstituted derivatives
Bioorganic & Medicinal Chemistry Letters 2001.0
Phthalazine PDE4 inhibitors. Part 3: The synthesis and in vitro evaluation of derivatives with a hydrogen bond acceptor
Bioorganic & Medicinal Chemistry Letters 2002.0
The synthesis and biological evaluation of a novel series of phthalazine PDE4 inhibitors I
Bioorganic & Medicinal Chemistry Letters 2000.0
Syntheses and evaluation of pyrido[2,3-d]pyrimidine-2,4-diones as PDE 4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2001.0
Novel Selective PDE4 Inhibitors. 2. Synthesis and Structure−Activity Relationships of 4-Aryl-Substituted cis-Tetra- and cis-Hexahydrophthalazinones
Journal of Medicinal Chemistry 2001.0
Synthesis and in vitro profile of a novel series of catechol benzimidazoles. The discovery of potent, selective phosphodiesterase type IV inhibitors with greatly attenuated affinity for the [3H]rolipram binding site
Bioorganic & Medicinal Chemistry Letters 1995.0
The synthesis and biological evaluation of a novel series of indole PDE4 inhibitors I
Bioorganic & Medicinal Chemistry Letters 1998.0
Novel Heterocyclic-Fused Pyridazinones as Potent and Selective Phosphodiesterase IV Inhibitors
Journal of Medicinal Chemistry 1997.0
Design, synthesis and in vitro PDE4 inhibition activity of certain quinazolinone derivatives for treatment of asthma
Medicinal Chemistry Research 2012.0
Discovery of micromolar PDE IV inhibitors that exhibit much reduced affinity for the [3H]rolipram binding site: 3-norbornyloxy-4-methoxyphenylmethylene oxindoles
Bioorganic & Medicinal Chemistry Letters 1995.0